Spinal Fusions Ineffective for Vertebral Fracture Pain
|
By HospiMedica International staff writers Posted on 05 Feb 2019 |
Vertebral augmentation procedures such as vertebroplasty and balloon kyphoplasty do not promote pain relief following vertebral fracture (VF), claims a new study.
Researchers at Monash University (Melbourne, Australia), Beth Israel Deaconess Medical Center (Boston, MA, USA), the University of Sheffield (United Kingdom), and other institutions conducted a systematic literature review and meta‐analysis of studies in order to address what is currently known (and not known) on the safety and efficacy of vertebral augmentation, including reviewing available evidence to assess if VF risk is increased following the procedure.
The review found that vertebroplasty did not provide significantly better pain control than placebo in five randomized placebo-controlled trials, but there was weak evidence of the benefit of kyphoplasty in one clinical trial when compared to nonsurgical management. Potential harms from vertebroplasty and balloon kyphoplasty, on the other hand, included cement leakage, adjacent fractures, and more serious adverse events. The evidence was unclear if these procedures increased the risk of VF or related serious adverse events.
The review also found no evidence that spinal bracing reduced pain immediately after VF, although low-quality evidence suggested that wearing a brace for two hours a day over six months might help. Neither was there was evidence that exercise may improve mobility, alleviate pain, and reduce fear of falling. The researchers did mention the critical importance of anti-osteoporotic medications, which can reduce the risk of subsequent vertebral fractures by 40-70%. The study was published on January 24, 2019, in the Journal of Bone and Mineral Research.
“The message for doctors and their patients suffering from painful spinal fractures is that procedures to stabilize spinal fractures should not be a first choice for treatment. We found no significant benefit over the long-term in improving pain, back-related disability, and quality of life when compared with those who did not have the procedures,” concluded lead author Peter Ebeling, MBBS, of Monash University, and colleagues. “This is a painful condition that for most people spontaneously gets better with time, and can be managed with analgesic medications over the short-term.”
Osteoporotic compression fractures of the vertebral body can result in pain and long-term morbidity, including spinal deformity. Conservative management includes opioids and other analgesics, bed rest, and a back brace. Surgical options include vertebroplasty, in which polymethylmethacrylate is injected into the fractured vertebral body; and balloon kyphoplasty, which uses a two-step process of inserting of a balloon device into the compacted vertebrae to attempt to restore it to a more normal shape before cement injection.
Related Links:
Monash University
Beth Israel Deaconess Medical Center
University of Sheffield
Researchers at Monash University (Melbourne, Australia), Beth Israel Deaconess Medical Center (Boston, MA, USA), the University of Sheffield (United Kingdom), and other institutions conducted a systematic literature review and meta‐analysis of studies in order to address what is currently known (and not known) on the safety and efficacy of vertebral augmentation, including reviewing available evidence to assess if VF risk is increased following the procedure.
The review found that vertebroplasty did not provide significantly better pain control than placebo in five randomized placebo-controlled trials, but there was weak evidence of the benefit of kyphoplasty in one clinical trial when compared to nonsurgical management. Potential harms from vertebroplasty and balloon kyphoplasty, on the other hand, included cement leakage, adjacent fractures, and more serious adverse events. The evidence was unclear if these procedures increased the risk of VF or related serious adverse events.
The review also found no evidence that spinal bracing reduced pain immediately after VF, although low-quality evidence suggested that wearing a brace for two hours a day over six months might help. Neither was there was evidence that exercise may improve mobility, alleviate pain, and reduce fear of falling. The researchers did mention the critical importance of anti-osteoporotic medications, which can reduce the risk of subsequent vertebral fractures by 40-70%. The study was published on January 24, 2019, in the Journal of Bone and Mineral Research.
“The message for doctors and their patients suffering from painful spinal fractures is that procedures to stabilize spinal fractures should not be a first choice for treatment. We found no significant benefit over the long-term in improving pain, back-related disability, and quality of life when compared with those who did not have the procedures,” concluded lead author Peter Ebeling, MBBS, of Monash University, and colleagues. “This is a painful condition that for most people spontaneously gets better with time, and can be managed with analgesic medications over the short-term.”
Osteoporotic compression fractures of the vertebral body can result in pain and long-term morbidity, including spinal deformity. Conservative management includes opioids and other analgesics, bed rest, and a back brace. Surgical options include vertebroplasty, in which polymethylmethacrylate is injected into the fractured vertebral body; and balloon kyphoplasty, which uses a two-step process of inserting of a balloon device into the compacted vertebrae to attempt to restore it to a more normal shape before cement injection.
Related Links:
Monash University
Beth Israel Deaconess Medical Center
University of Sheffield
Latest Critical Care News
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
- Cancer-Seeking Microbubbles Make Tumor Cells Self-Destruct
- Eye Movement Tests Uncover Hidden Brain Changes Years After Concussion
Channels
Artificial Intelligence
view channel
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
AI Tool Maps Early Risk Patterns in Bloodstream Infections
Bloodstream infections can deteriorate rapidly and carry high mortality, especially in immunocompromised patients. Clinicians need reliable early risk stratification to prioritize monitoring and organ support.... Read moreSurgical Techniques
view channel
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Handheld Robotic System Expands Options for Total Knee Surgery
Orthopedic teams vary in their adoption of robotics, with some surgeons favoring intraoperative decision-making and a manual instrument feel, while others rely on preoperative, computed tomography–based... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channelMedtronic and GE HealthCare Broaden Alliance Across Monitoring and Care Solutions
Medtronic announced a multiyear renewal and significant expansion of its global strategic alliance with GE HealthCare across Patient Care Solutions. Building on more than three decades of collaboration,... Read more
Quantum Surgical Acquires NeuWave from Johnson & Johnson
Quantum Surgical announced that it has acquired NeuWave Medical from Johnson & Johnson. NeuWave’s microwave ablation system is used in percutaneous tumor ablation procedures, and the acquisition supports... Read more
Medtronic to Acquire Coronary Artery Medtech Company CathWorks
Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more







